These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Probing the correlation between insulin activity and structural stability through introduction of the rigid A6-A11 bond. Ong SC; Belgi A; van Lierop B; Delaine C; Andrikopoulos S; MacRaild CA; Norton RS; Haworth NL; Robinson AJ; Forbes BE J Biol Chem; 2018 Jul; 293(30):11928-11943. PubMed ID: 29899115 [TBL] [Abstract][Full Text] [Related]
46. Preparation of a microcrystalline suspension formulation of Lys(B28)Pro(B29)-human insulin with ultralente properties. Richards JP; Stickelmeyer MP; Frank BH; Pye S; Barbeau M; Radziuk J; Smith GD; DeFelippis MR J Pharm Sci; 1999 Sep; 88(9):861-7. PubMed ID: 10479347 [TBL] [Abstract][Full Text] [Related]
47. Recombinant human insulin analogues: recommendations for optimal use. Torlone E BioDrugs; 1998 May; 9(5):363-74. PubMed ID: 18020571 [TBL] [Abstract][Full Text] [Related]
48. Altering the association properties of insulin by amino acid replacement. Brems DN; Alter LA; Beckage MJ; Chance RE; DiMarchi RD; Green LK; Long HB; Pekar AH; Shields JE; Frank BH Protein Eng; 1992 Sep; 5(6):527-33. PubMed ID: 1438163 [TBL] [Abstract][Full Text] [Related]
49. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. DiMarchi RD; Chance RE; Long HB; Shields JE; Slieker LJ Horm Res; 1994; 41 Suppl 2():93-6. PubMed ID: 8088710 [TBL] [Abstract][Full Text] [Related]
50. Insulin lispro: a new quick-acting insulin analogue. Gale EA Expert Opin Investig Drugs; 1997 Sep; 6(9):1247-56. PubMed ID: 15991899 [TBL] [Abstract][Full Text] [Related]